Xinjun Lu

870 total citations
28 papers, 433 citations indexed

About

Xinjun Lu is a scholar working on Molecular Biology, Surgery and Hepatology. According to data from OpenAlex, Xinjun Lu has authored 28 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Hepatology. Recurrent topics in Xinjun Lu's work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Viral Infections and Vectors (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Xinjun Lu is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Viral Infections and Vectors (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Xinjun Lu collaborates with scholars based in China, United States and Germany. Xinjun Lu's co-authors include Xin Chen, Diego F. Calvisi, Panagiotis Paliogiannis, Matthias Evert, Jingxiao Wang, Zhi Lü, Xinhua Song, Kirsten Utpatel, Li Che and Meng Xu and has published in prestigious journals such as Journal of Clinical Investigation, Hepatology and Gut.

In The Last Decade

Xinjun Lu

27 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinjun Lu China 12 146 81 81 79 77 28 433
Yuan Hu China 15 183 1.3× 48 0.6× 150 1.9× 31 0.4× 69 0.9× 52 584
Narges Zali Iran 12 88 0.6× 52 0.6× 72 0.9× 114 1.4× 54 0.7× 17 408
Zerui Zhang China 10 136 0.9× 156 1.9× 69 0.9× 15 0.2× 37 0.5× 19 419
Xiaodan Yang China 10 125 0.9× 57 0.7× 38 0.5× 27 0.3× 55 0.7× 31 412
Naoko Goto Japan 11 226 1.5× 42 0.5× 107 1.3× 29 0.4× 33 0.4× 27 453
Markus Zojer Austria 9 241 1.7× 32 0.4× 133 1.6× 34 0.4× 54 0.7× 13 449
Baorong Chi China 13 171 1.2× 23 0.3× 45 0.6× 48 0.6× 74 1.0× 32 342
Zhongliang Shen China 16 258 1.8× 61 0.8× 72 0.9× 167 2.1× 124 1.6× 39 582
Yue Peng China 8 288 2.0× 32 0.4× 53 0.7× 142 1.8× 139 1.8× 13 628
Yujia Zhai China 12 154 1.1× 11 0.1× 33 0.4× 68 0.9× 68 0.9× 23 377

Countries citing papers authored by Xinjun Lu

Since Specialization
Citations

This map shows the geographic impact of Xinjun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinjun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinjun Lu more than expected).

Fields of papers citing papers by Xinjun Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinjun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinjun Lu. The network helps show where Xinjun Lu may publish in the future.

Co-authorship network of co-authors of Xinjun Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinjun Lu. A scholar is included among the top collaborators of Xinjun Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinjun Lu. Xinjun Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jingchang, et al.. (2025). Advances in Tumor Microenvironment and Immunotherapeutic Strategies for Hepatocellular Carcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 33(9). 2309–2329. 1 indexed citations
2.
Zhang, Honghua, Xiuxian Li, Yang Liu, et al.. (2025). Tumor necrosis facilitates perihilar cholangiocarcinoma metastasis by ANGPTL6-augmented vessel permeability and tumor dissemination. JHEP Reports. 7(10). 101514–101514.
3.
4.
Deng, Shanshan, Xinjun Lu, Xue Wang, et al.. (2024). Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma. Cell Death and Disease. 15(6). 441–441. 1 indexed citations
5.
Lu, Xinjun, Qi Zhu, Junfeng Cai, et al.. (2024). Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation. Cancer Immunology Immunotherapy. 74(1). 18–18. 3 indexed citations
6.
Lu, Xinjun, Ya Zhang, Matthias Evert, et al.. (2024). MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma. Toxicological Sciences. 203(1). 41–51. 3 indexed citations
7.
Lu, Xinjun, Benjamin L. Green, Changqing Xie, Chao Liu, & Xin Chen. (2023). Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma. JHEP Reports. 5(7). 100723–100723. 9 indexed citations
8.
Lu, Xinjun, Shanshan Deng, Benjamin L. Green, et al.. (2023). Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models. Journal of Clinical Investigation. 133(11). 27 indexed citations
9.
Zhang, Long, Weiqi Liao, Shimin Chen, et al.. (2023). Towards a New 3Rs Era in the construction of 3D cell culture models simulating tumor microenvironment. Frontiers in Oncology. 13. 1146477–1146477. 12 indexed citations
10.
Wei, Min, et al.. (2023). The role of ROS-pyroptosis in PM2.5 induced air-blood barrier destruction. Chemico-Biological Interactions. 386. 110782–110782. 7 indexed citations
11.
Wei, Min, et al.. (2023). PM2.5 induce myocardial injury in hyperlipidemic mice through ROS-pyroptosis signaling pathway. Ecotoxicology and Environmental Safety. 254. 114699–114699. 12 indexed citations
12.
Chen, Yukun, Yujun Liu, Shimin Chen, et al.. (2023). Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer. Frontiers in Immunology. 14. 1180184–1180184. 14 indexed citations
13.
Lu, Xinjun, Baogang Peng, Ge Chen, et al.. (2021). YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice. American Journal Of Pathology. 191(9). 1651–1667. 11 indexed citations
14.
Lu, Xinjun, Panagiotis Paliogiannis, Diego F. Calvisi, & Xin Chen. (2020). Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies. Hepatology. 73(S1). 49–61. 93 indexed citations
15.
Shang, Runze, Xinhua Song, Pan Wang, et al.. (2020). Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma. Gut. 70(9). 1746–1757. 75 indexed citations
16.
Liu, Xianqiong, Junjie Hu, Xinhua Song, et al.. (2019). Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma. Cancers. 11(7). 930–930. 11 indexed citations
17.
Chen, Maogen, et al.. (2017). Dendritic Cells Transduced with Single Immunoglobulin IL-1-Related Receptor Exhibit Immature Properties and Prolong Islet Allograft Survival. Frontiers in Immunology. 8. 1671–1671. 12 indexed citations
18.
Lu, Xinjun, Maogen Chen, Jiejie Xu, et al.. (2017). Dendritic cells that highly express SOCS1 induce T-cell hypo-responsiveness and prolong islet allograft survival. Cellular Immunology. 314. 36–41. 9 indexed citations
19.
Xu, Jiejie, et al.. (2017). A modified method for isolating mouse islets of an adequate quality, quantity, and purity. Biochemistry and Cell Biology. 95(4). 455–458. 2 indexed citations
20.
Lü, Zhi, Xinjun Lu, Shi Hong Fu, et al.. (2009). Tahyna Virus and Human Infection, China. Emerging infectious diseases. 15(2). 306–309. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuan Hu Breakdown of academic impact, for papers by Narges Zali Breakdown of academic impact, for papers by Zerui Zhang Breakdown of academic impact, for papers by Xiaodan Yang Breakdown of academic impact, for papers by Naoko Goto Breakdown of academic impact, for papers by Markus Zojer Breakdown of academic impact, for papers by Baorong Chi Breakdown of academic impact, for papers by Zhongliang Shen Breakdown of academic impact, for papers by Yue Peng Breakdown of academic impact, for papers by Yujia Zhai
Rankless by CCL
2026